Ketamine Research Treatment Study for Pediatric Refractory Obsessive-Compulsive Disorder (OCD)

Eligibility Criteria

Male and Female, ages 14-20:

  • Diagnosed with OCD
  • Tried at least two SRI medications and CBT with little or no change in OCD symptoms
New York

Researchers at Columbia University/New York State Psychiatric Institute are conducting an experimental treatment study for pediatric OCD. The study aims to determine whether ketamine, an anesthetic medication, can cause a rapid decrease in OCD symptoms. Eligible participants will receive a free, thorough diagnostic evaluation, and a one-time low dose of intravenous ketamine. Participants will be monitored by clinical staff for two weeks following the ketamine infusion.

College-Aged Adults Face Less Mental Health Stigma

College-aged adults (age 18–25) have more accepting views of mental health care than other adults, but they still see challenges when it comes to accessing care, according to results of a nationwide poll. The survey was conducted online among more than 2,000 adults, including 198 age 18–25, by Harris Poll on behalf of Anxiety and Depression Association of America (ADAA) and two partnering organizations.

Novel Medication Strategies Targeting Brain Mechanisms in Pediatric OCD

Eligibility Criteria

Male and female, ages 8-20:

  • Diagnosed with OCD
  • Currently taking an antidepressant and still experiences OCD symptoms
New York

This study aims to determine whether adding an FDA-approved antibiotic medication called minocycline to antidepressant treatment can help reduce symptoms of pediatric OCD. This study also aims to learn more about the brains of children, adolescents and young adults with OCD.

Treating Anxiety and Depression in the Transitional Years (Ages 18-25)

Anne Marie Albano, PhD, ABPP

Associate Professor of Clinical Psychology in Psychiatry
Director, Columbia University Clinic for Anxiety and Related Disorders
Columbia University Medical Center

Co-Clinical Director, Youth Anxiety Center
New York-Presbyterian Hospital

Dr. Albano describes the so-called transitional years, or emerging adults ages 18 to 25, and what makes this a unique group when it comes to treating anxiety, OCD, and depression.